The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PSMT, LTHM and TEVA
Monday, July 8, 2019 12:25 PM
NEW YORK, NY / ACCESSWIRE / July 8, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
PriceSmart, Inc. (NASDAQGS: PSMT)
Class Period: October 26, 2017 to October 25, 2018
Lead Plaintiff Deadline: July 22, 2019
The lawsuit alleges that PriceSmart, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s omni-channel business strategy had failed to reach key operating goals; (2) the Company’s South America distribution strategy had failed to realize key cost saving goals; (3) the Company had invested Trinidad and Tobago dollars into certificates of deposits with financial institutions; (4) that these investments had been improperly classified as cash and cash equivalents; (5) the relevant corrections would materially impact financial statements; (6) there was a material weakness in the Company’s internal controls over financial reporting; (7) increasing competition negatively impacted the Company’s revenue and profitability; and (8) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Get additional information about the PSMT lawsuit: http://www.kleinstocklaw.com/pslra-1/pricesmart-inc-loss-submission-form?id=2275&from=1
Livent Corporation (NYSE: LTHM)
Class Period: on behalf of persons and entities that purchased or otherwise acquired Livent securities pursuant and/or traceable to initial public offering on or around October 11, 2018.
Lead Plaintiff Deadline: July 22, 2019
The complaint alleges Livent Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) a supply contract with Nemaska Lithium Inc. had been terminated; (2) as a result, the Company would be forced to fulfill its customer contracts using alternative vendors at reduced revenues and lower margins; (3) the Company had a long-standing contract to supply lithium hydroxide to a customer at a much lower price than any of the Company's existing contracts; (4) the Company's margins were squeezed due to the customer's increased orders; and (5) as a result of the foregoing, Defendants positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Get additional information about the LTHM lawsuit: http://www.kleinstocklaw.com/pslra-1/livent-corporation-loss-submission-form?id=2275&from=1
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)
Class Period: on behalf of all persons or entities who purchased or otherwise acquired Teva American Depositary Shares (“ADS”) between August 4, 2017 and May 10, 2019
Lead Plaintiff Deadline: August 23, 2019
According to the complaint, Teva Pharmaceutical Industries Ltd. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.
Get additional information about the TEVA lawsuit: http://www.kleinstocklaw.com/pslra-1/teva-pharmaceutical-industries-ltd-loss-submission-form?id=2275&from=1
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
SOURCE: The Klein Law Firm